Bálint Liktor, Andor Hirschberg, Tamás Karosi, Balázs Liktor
{"title":"[Otosclerosis].","authors":"Bálint Liktor, Andor Hirschberg, Tamás Karosi, Balázs Liktor","doi":"10.1556/650.2024.33110","DOIUrl":null,"url":null,"abstract":"<p><p>Otosclerosis is a bone remodeling disorder with still unclear origin, which exclusively forms tiny foci in the human temporal bone. These foci most often develop in the anterior part of the oval window niche and in the stapes footplate, and mechanically fix the ossicles, causing a consequent conductive hearing loss. In relation to the treatment of otosclerosis, it is a natural demand to try to reverse the progression of the disease with various medical treatment options, but until now only bone remodeling has been slowed down. Sodium fluoride and bisphosphonate treatment have shown to be highly promising, but due to their serious side effects, they can only be considered in exceptional cases. There is still great hope for targeted (biological) therapies, but they are not yet approved in Hungary. The „gold standard” procedure for otosclerosis is the surgical solution, which does not cure the disease, just simply eliminates the conductive component of the hearing loss. The older stapedectomy is increasingly being replaced by the technically simpler stapedotomy, however, they are still considered almost equivalent procedures in the literature. In addition to standard microscopic stapes surgery, the most modern endoscopic stapedotomy is also presented. Orv Hetil. 2024; 165(32): 1237–1241.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"165 32","pages":"1237-1241"},"PeriodicalIF":0.9000,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2024.33110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Otosclerosis is a bone remodeling disorder with still unclear origin, which exclusively forms tiny foci in the human temporal bone. These foci most often develop in the anterior part of the oval window niche and in the stapes footplate, and mechanically fix the ossicles, causing a consequent conductive hearing loss. In relation to the treatment of otosclerosis, it is a natural demand to try to reverse the progression of the disease with various medical treatment options, but until now only bone remodeling has been slowed down. Sodium fluoride and bisphosphonate treatment have shown to be highly promising, but due to their serious side effects, they can only be considered in exceptional cases. There is still great hope for targeted (biological) therapies, but they are not yet approved in Hungary. The „gold standard” procedure for otosclerosis is the surgical solution, which does not cure the disease, just simply eliminates the conductive component of the hearing loss. The older stapedectomy is increasingly being replaced by the technically simpler stapedotomy, however, they are still considered almost equivalent procedures in the literature. In addition to standard microscopic stapes surgery, the most modern endoscopic stapedotomy is also presented. Orv Hetil. 2024; 165(32): 1237–1241.
期刊介绍:
The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history.
Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary.
The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.